Pages that link to "Q37209917"
Jump to navigation
Jump to search
The following pages link to Gender and sex hormones in multiple sclerosis pathology and therapy. (Q37209917):
Displaying 34 items.
- Remyelination Therapy in Multiple Sclerosis (Q26772359) (← links)
- Neuroendocrine immunoregulation in multiple sclerosis (Q26864449) (← links)
- A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy (Q33735281) (← links)
- Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated. (Q34220882) (← links)
- Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes (Q35145298) (← links)
- Association of the SPT2 chromatin protein domain containing 1 gene rs17579600 polymorphism and serum lipid traits (Q36375290) (← links)
- Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis (Q36475281) (← links)
- Evaluating sex hormone levels in reproductive age women with multiple sclerosis and their relationship with disease severity (Q36969399) (← links)
- Sex differences in the physiology and pharmacology of the lower urinary tract (Q37198062) (← links)
- The relation between peptide hormones and sex hormone in patients with multiple sclerosis (Q37311747) (← links)
- The chronic blockade of angiotensin I-converting enzyme eliminates the sex differences of serum cytokine levels of spontaneously hypertensive rats. (Q37371365) (← links)
- 17β-Estradiol Promotes Schwann Cell Proliferation and Differentiation, Accelerating Early Remyelination in a Mouse Peripheral Nerve Injury Model. (Q37410763) (← links)
- Is multiple sclerosis a mitochondrial disease? (Q37466077) (← links)
- Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis (Q37548624) (← links)
- Prostaglandins in pathogenesis and treatment of multiple sclerosis (Q37710103) (← links)
- Gender issues in multiple sclerosis: an update (Q37813691) (← links)
- Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis (Q37834024) (← links)
- Hormone and immune system interactions in demyelinating disease (Q38058619) (← links)
- The potential role of iNKT cells in experimental allergic encephalitis and multiple sclerosis. (Q38193865) (← links)
- Sex disparities in neuro-ophthalmologic disorders (Q38218704) (← links)
- The role of epidemiology in MS research: Past successes, current challenges and future potential (Q38376270) (← links)
- Peripheral Inflammation and Demyelinating Diseases (Q38974745) (← links)
- Sex Difference in Oxidative Stress Parameters in Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis: Relation to Neurological Deficit (Q39216225) (← links)
- The promyelinating properties of androstenediol in gliotoxin-induced demyelination in rat corpus callosum. (Q41197337) (← links)
- Association between multiple sclerosis and chronic periodontitis: a population-based pilot study (Q42275549) (← links)
- Effect of gender on late-onset multiple sclerosis (Q44916829) (← links)
- Embolization of a large progressive symptomatic desmoid tumor in the rectus muscle of a female patient with multiple sclerosis: a case report. (Q47721779) (← links)
- Pharmacotherapy with 17β-estradiol and progesterone prevents development of mouse experimental autoimmune encephalomyelitis (Q48361546) (← links)
- Gender-related differences in functional connectivity in multiple sclerosis (Q48906222) (← links)
- Retinal nerve fiber layer sector-specific compromise in relapsing and remitting multiple sclerosis (Q49994724) (← links)
- Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients (Q58874343) (← links)
- Hormesis and Female Sex Hormones (Q60537409) (← links)
- Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis (Q61444780) (← links)
- An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis (Q87973354) (← links)